Kyle B. Stephenson

1.8k total citations
27 papers, 1.3k citations indexed

About

Kyle B. Stephenson is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Kyle B. Stephenson has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 16 papers in Oncology and 16 papers in Immunology. Recurrent topics in Kyle B. Stephenson's work include Virus-based gene therapy research (21 papers), CAR-T cell therapy research (12 papers) and Immunotherapy and Immune Responses (12 papers). Kyle B. Stephenson is often cited by papers focused on Virus-based gene therapy research (21 papers), CAR-T cell therapy research (12 papers) and Immunotherapy and Immune Responses (12 papers). Kyle B. Stephenson collaborates with scholars based in Canada, United States and China. Kyle B. Stephenson's co-authors include Brian D. Lichty, Yonghong Wan, Jonathan L. Bramson, Jeanette E. Boudreau, Byram W. Bridle, Sandeep T. Koshy, Ali A. Ashkar, David F. Stojdl, John C. Bell and Elizabeth R. Davies and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Kyle B. Stephenson

26 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kyle B. Stephenson Canada	20	778	767	502	385	212	27	1.3k
Dominic G. Roy Canada	18	708 0.9×	644 0.8×	391 0.8×	466 1.2×	152 0.7×	31	1.2k
Karen J. Scott United Kingdom	20	628 0.8×	657 0.9×	427 0.9×	314 0.8×	213 1.0×	33	1.2k
Laura Evgin United States	16	646 0.8×	639 0.8×	261 0.5×	378 1.0×	114 0.5×	28	987
Feorillo Galivo United States	17	1.0k 1.3×	706 0.9×	396 0.8×	443 1.2×	186 0.9×	21	1.3k
Elizabeth J. Ilett United Kingdom	24	1.2k 1.6×	1.2k 1.5×	602 1.2×	541 1.4×	397 1.9×	38	1.9k
Johanna K. Kaufmann Germany	13	497 0.6×	551 0.7×	325 0.6×	451 1.2×	135 0.6×	26	1.0k
Roshni Ravindranathan United States	12	727 0.9×	805 1.0×	432 0.9×	337 0.9×	103 0.5×	17	1.1k
Murielle Gantzer France	8	620 0.8×	400 0.5×	209 0.4×	544 1.4×	127 0.6×	13	915
Minna Oksanen Finland	17	726 0.9×	666 0.9×	210 0.4×	367 1.0×	113 0.5×	24	884
Hongjie Wang United States	23	904 1.2×	444 0.6×	177 0.4×	903 2.3×	178 0.8×	49	1.4k

Countries citing papers authored by Kyle B. Stephenson

Since Specialization

Citations

This map shows the geographic impact of Kyle B. Stephenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle B. Stephenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle B. Stephenson more than expected).

Fields of papers citing papers by Kyle B. Stephenson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle B. Stephenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle B. Stephenson. The network helps show where Kyle B. Stephenson may publish in the future.

Co-authorship network of co-authors of Kyle B. Stephenson

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle B. Stephenson. A scholar is included among the top collaborators of Kyle B. Stephenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle B. Stephenson. Kyle B. Stephenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roy, Dominic G., Monique Marguerie, S. Khan, et al.. (2021). Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination. Nature Communications. 12(1). 2626–2626. 51 indexed citations

McGray, AJ Robert, Cheryl Eppolito, Anthony Miliotto, et al.. (2021). A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer. Cancer Immunology Immunotherapy. 70(12). 3451–3460. 11 indexed citations

Pol, Jonathan, Matthew J. Atherton, Kyle B. Stephenson, et al.. (2020). Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning. Journal for ImmunoTherapy of Cancer. 8(2). e000981–e000981. 19 indexed citations

McGray, AJ Robert, Ruea-Yea Huang, Sebastiano Battaglia, et al.. (2019). Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer. Journal for ImmunoTherapy of Cancer. 7(1). 189–189. 45 indexed citations

Atherton, Matthew J., Kyle B. Stephenson, Jake K. Nikota, et al.. (2018). Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer. Vaccine. 36(16). 2181–2192. 23 indexed citations

Pol, Jonathan, Matthew J. Atherton, Byram W. Bridle, et al.. (2018). Development and applications of oncolytic Maraba virus vaccines. PubMed. Volume 7. 117–128. 38 indexed citations

Atherton, Matthew J., Kyle B. Stephenson, Fanny Tzelepis, et al.. (2018). Transforming the prostatic tumor microenvironment with oncolytic virotherapy. OncoImmunology. 7(7). e1445459–e1445459. 23 indexed citations

Atherton, Matthew J., Kyle B. Stephenson, Jonathan Pol, et al.. (2017). Customized Viral Immunotherapy for HPV-Associated Cancer. Cancer Immunology Research. 5(10). 847–859. 32 indexed citations

Bienzle, Dorothee, Kyle B. Stephenson, J Delay, et al.. (2017). Maraba virus-vectored cancer vaccines represent a safe and novel therapeutic option for cats. Scientific Reports. 7(1). 15738–15738. 10 indexed citations

10.

Ananth, Abhirami A., Lee‐Hwa Tai, Almohanad A. Alkayyal, et al.. (2016). Surgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer Recurrence. PLoS ONE. 11(5). e0155947–e0155947. 61 indexed citations

11.

Kwiecień, Jacek M., Snezana Milosavljevic, Robin Hallett, et al.. (2016). Kaiso depletion attenuates transforming growth factor-β signaling and metastatic activity of triple-negative breast cancer cells. Oncogenesis. 5(3). e208–e208. 31 indexed citations

12.

Zhang, Jiqing, Lee‐Hwa Tai, Carolina S. Ilkow, et al.. (2014). Maraba MG1 Virus Enhances Natural Killer Cell Function via Conventional Dendritic Cells to Reduce Postoperative Metastatic Disease. Molecular Therapy. 22(7). 1320–1332. 54 indexed citations

13.

Pol, Jonathan, Liang Zhang, Byram W. Bridle, et al.. (2013). Maraba Virus as a Potent Oncolytic Vaccine Vector. Molecular Therapy. 22(2). 420–429. 128 indexed citations

14.

Stephenson, Kyle B., Nicole G. Barra, Elizabeth R. Davies, Ali A. Ashkar, & Brian D. Lichty. (2011). Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity. Cancer Gene Therapy. 19(4). 238–246. 96 indexed citations

15.

Boudreau, Jeanette E., Kyle B. Stephenson, Fuan Wang, et al.. (2011). IL-15 and Type I Interferon Are Required for Activation of Tumoricidal NK Cells by Virus-Infected Dendritic Cells. Cancer Research. 71(7). 2497–2506. 45 indexed citations

16.

Boudreau, Jeanette E., et al.. (2010). Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic Virotherapy. Molecular Therapy. 19(2). 335–344. 78 indexed citations

17.

Bridle, Byram W., Kyle B. Stephenson, Jeanette E. Boudreau, et al.. (2010). Potentiating Cancer Immunotherapy Using an Oncolytic Virus. Molecular Therapy. 18(8). 1430–1439. 140 indexed citations

18.

Boudreau, Jeanette E., Byram W. Bridle, Kyle B. Stephenson, et al.. (2009). Recombinant Vesicular Stomatitis Virus Transduction of Dendritic Cells Enhances Their Ability to Prime Innate and Adaptive Antitumor Immunity. Molecular Therapy. 17(8). 1465–1472. 61 indexed citations

19.

Bridle, Byram W., Jeanette E. Boudreau, Brian D. Lichty, et al.. (2009). Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus. Molecular Therapy. 17(10). 1814–1821. 88 indexed citations

20.

Brown, Chris W., Kyle B. Stephenson, Michael Jonathan Kucharczyk, et al.. (2008). The p14 FAST Protein of Reptilian Reovirus Increases Vesicular Stomatitis Virus Neuropathogenesis. Journal of Virology. 83(2). 552–561. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact